Your Source for Venture Capital and Private Equity Financings

Pi Health Grabs Over $30M Series A Funding

CAMBRIDGE, MA, Pi Health today announced over $30 million in Series A funding.
Pi Health, an oncology-focused health technology and clinical research company committed to transforming global access to innovative medicines and clinical trials, today announced over $30M in Series A funding. Pi Health, which incubated as a subsidiary of BeiGene, Ltd. (NASDAQ: BGNE) three years ago, completed its fundraise to launch as an independent company. The round was led by AlleyCorp and Obvious Ventures, with additional investments from Invus Capital and leaders in oncology from across the globe.

Pi Health is an oncology clinical trial and research technology company committed to transforming global access to innovative medicines. Founded in 2021, the team is focused on empowering life science companies to develop medicines faster and reach diverse patient populations via their clinical trial platform. The organization's health system partnerships include oncology centers across the US, Brazil, Australia and India, as well as a new cancer hospital in Hyderabad, India, which embodies Pi Health's mission to bring modern, efficient and equitable trials to populations worldwide.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors